Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study. [electronic resource]
Producer: 19930916Description: 1733-42 p. digitalISSN:- 0008-543X
- Aged
- Aged, 80 and over
- Carcinoma, Renal Cell -- blood
- Drug Administration Schedule
- Drug Combinations
- Female
- Humans
- Infusions, Intravenous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interferon-gamma -- blood
- Interleukin-2 -- administration & dosage
- Interleukin-6 -- blood
- Kidney Neoplasms -- blood
- Leukocyte Count
- Lymphocyte Subsets -- pathology
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- therapy
- Receptors, Interleukin-2 -- analysis
- Recombinant Proteins
- Remission Induction
- T-Lymphocyte Subsets -- pathology
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.